Investigators from the Biomedical Research Institute of Malaga [(IBIMA)-CIMES-UMA, Malaga Spain] and collaborators have published the first pilot study to examine the use of a non-invasive liquid…
Oxford Gene Technology (OGT), A Sysmex Group Company, has celebrated the opening of its new facility in Cambridge, UK. The opening ceremony, which took place at the company’s new premises on the…
Using urine to obtain diagnostic insights has been done for thousands of years and still remains an important tool to obtain crucial information. Covering a range of tests, urinalysis may be used to…
The reasons why doctors request urinary analysis are varied – perhaps to detect a possible or suspected infection, or to screen for kidney diseases. In all cases a reliable and rapid result is the…
Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation, a Japanese in vitro diagnostic company.
Our mission at the Sysmex Corporation is defined very clearly in our corporate policy: in all that we do, our focus must be on Shaping the Advancement of Healthcare. Of course, there are a million…
Founded in 1968, The Sysmex Corporation has challenged its way past far larger companies to become one of the leading healthcare companies around the world. How? By focusing constantly on one…
Sysmex urine fluorescence flow cytometers offer a wide variety of clinical benefits to the user, including determination of WBC, bacteria and yeasts to exclude urinary tract infections and/or…
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.